ES2196281T3 - APPLICATION OF SUBSTITUTED STEROID COMPOUNDS IN POSITION 11 FOR THE MANUFACTURE OF MEDICINES WITH DISPOSED STROGEN ACTIVITY. - Google Patents

APPLICATION OF SUBSTITUTED STEROID COMPOUNDS IN POSITION 11 FOR THE MANUFACTURE OF MEDICINES WITH DISPOSED STROGEN ACTIVITY.

Info

Publication number
ES2196281T3
ES2196281T3 ES97403115T ES97403115T ES2196281T3 ES 2196281 T3 ES2196281 T3 ES 2196281T3 ES 97403115 T ES97403115 T ES 97403115T ES 97403115 T ES97403115 T ES 97403115T ES 2196281 T3 ES2196281 T3 ES 2196281T3
Authority
ES
Spain
Prior art keywords
strogen
medicines
activity
manufacture
disposed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97403115T
Other languages
Spanish (es)
Inventor
Yamina Bouali
Francois Nique
Daniel Philibert
Jean-Georges Teutsch
De Velde Patrick Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of ES2196281T3 publication Critical patent/ES2196281T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Use of 11-phenyl steroid derivatives of formula (I) and their salts in hormone replacement therapy to treat the effects of the menopause or perimenopause. n = 2 or 3; R1, R2 = H or 1-4C alkyl; or NR1R2 = 5-15 membered optionally unsaturated, mono- or poly-cyclic heterocycle which may contain 1-3 further hetero atoms selected from O, N, S and which may be substituted; X = OH (optionally esterified); and Y = H, 2-4C alkenyl or 2-4C alkynyl; or X+Y = a group of formula (ii), (iii) or (iv); or X+Y = oxo.
ES97403115T 1996-12-23 1997-12-22 APPLICATION OF SUBSTITUTED STEROID COMPOUNDS IN POSITION 11 FOR THE MANUFACTURE OF MEDICINES WITH DISPOSED STROGEN ACTIVITY. Expired - Lifetime ES2196281T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615828A FR2757399B1 (en) 1996-12-23 1996-12-23 APPLICATION OF 11-SUBSTITUTED STEROID COMPOUNDS FOR THE MANUFACTURE OF DRUGS HAVING DISSOCIATED ESTROGEN ACTIVITY

Publications (1)

Publication Number Publication Date
ES2196281T3 true ES2196281T3 (en) 2003-12-16

Family

ID=9498982

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97403115T Expired - Lifetime ES2196281T3 (en) 1996-12-23 1997-12-22 APPLICATION OF SUBSTITUTED STEROID COMPOUNDS IN POSITION 11 FOR THE MANUFACTURE OF MEDICINES WITH DISPOSED STROGEN ACTIVITY.

Country Status (7)

Country Link
US (2) US5981516A (en)
EP (1) EP0850647B1 (en)
JP (1) JP4263264B2 (en)
AT (1) ATE235243T1 (en)
DE (1) DE69720160T2 (en)
ES (1) ES2196281T3 (en)
FR (1) FR2757399B1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757519B1 (en) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc SUBSTITUTED STEROIDS IN POSITION 11, THEIR PREPARATION PROCESS, THEIR APPLICATION AS A MEDICAMENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US6172052B1 (en) 1998-12-04 2001-01-09 Research Triangle Institute 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
DE19929715A1 (en) * 1999-06-24 2000-12-28 Schering Ag New 11-beta-long chain substituted estratriene derivatives, are antiestrogens or tissue-selective partial estrogens useful e.g. for treating hormone-dependent cancer or osteoporosis
CN101316558B (en) 2005-09-27 2013-03-27 帕拉迪格脊骨有限责任公司 Interspinous vertebral stabilization devices
US20080103116A1 (en) * 2006-11-01 2008-05-01 Jennings-Spring Barbara L Method of treatment and compositions of D-chiro inositol and phosphates thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4978657A (en) * 1981-01-09 1990-12-18 Roussel Uclaf Novel 11β-substituted-19-nor-steroids
FR2528434B1 (en) * 1982-06-11 1985-07-19 Roussel Uclaf NOVEL 19-NOR STEROIDS SUBSTITUTED IN 11B AND POSSIBLY IN 2, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS A MEDICAMENT
FR2640977A2 (en) * 1982-06-11 1990-06-29 Roussel Uclaf New position-11 substituted 19-norsteroids and their application as medicinal products.
FR2596395B1 (en) * 1986-03-26 1989-05-26 Roussel Uclaf NOVEL STEROIDS COMPRISING A SPIRANIC CYCLE IN POSITION 17, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
FR2618783B1 (en) * 1987-07-30 1991-02-01 Roussel Uclaf NOVEL 17-ARYL STEROIDS, THEIR PROCESSES AND INTERMEDIATES AS A MEDICAMENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US4925816A (en) * 1987-08-29 1990-05-15 Ngk Insulators, Ltd. Novel solid solution, heat-resistant sintered body and method of producing the same
FR2620707B1 (en) * 1987-09-18 1989-12-08 Roussel Uclaf NOVEL STEROIDS COMPRISING A 3, 4 OR 6-CHAIN SPIRANIC CYCLE IN POSITION 17, THEIR PROCESS AND PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
DE69720160T2 (en) 2003-11-13
US6011026A (en) 2000-01-04
ATE235243T1 (en) 2003-04-15
JPH10182466A (en) 1998-07-07
FR2757399B1 (en) 1999-12-17
EP0850647B1 (en) 2003-03-26
JP4263264B2 (en) 2009-05-13
US5981516A (en) 1999-11-09
FR2757399A1 (en) 1998-06-26
EP0850647A1 (en) 1998-07-01
DE69720160D1 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
ES2077948T3 (en) PREPARATION FOR EXTERNAL SKIN CARE.
GEP20022803B (en) Steroid Sulphatase Inhibitors
IL175398A0 (en) Steroidal compounds and pharmaceutical compositions containing them for treating oxidative stress and inflammation
EP0694546A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
EP0627442A4 (en) Lewis-type sugar chain derivative.
ES2196281T3 (en) APPLICATION OF SUBSTITUTED STEROID COMPOUNDS IN POSITION 11 FOR THE MANUFACTURE OF MEDICINES WITH DISPOSED STROGEN ACTIVITY.
IL91047A (en) Zinc complexes for the treatment of free radical- induced diseases
MY106314A (en) New tetrazole derivatives, process for their preparation and their use
ES2090083T3 (en) CEPHALOSPORIN DERIVATIVES, PROCEDURE FOR THE PREPARATION AND ANTIMICROBIAL COMPOSITION CONTAINING THESE DERIVATIVES.
HU9202642D0 (en) Method for producing piperidine derivatives and pharmaceutical preparatives containing said compounds as active substance
EP0451869A3 (en) Use of steroid derivatives in the treatment of endometriosis
HU228233B1 (en) Antipruritic agents for external use
EP0676202A3 (en) Use of aromatic steroids substituted in 3-position by a disubstituted aminoalkoxy chain for the manufacture of a medicament for the control of fertility, in particular male fertility.
EP0548558A3 (en) Compositions containing surfactants as potentiating agents for the treatment of mammalian diseases
DE69414396T2 (en) ACYLPHENYLGLYCIN DERIVATIVE AND THIS PREVENTIVE AND HEALING AGENT CONTAINING ACTIVE SUBSTANCES AGAINST DISEASES CAUSED BY INCREASED COLLAGENASE ACTIVITY
AR010857A1 (en) SUBSTITUTED STEROIDS IN POSITION 11, THEIR PREPARATION PROCEDURE, THEIR APPLICATION AS A MEDICINAL PRODUCT AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
DE69200365D1 (en) Pharmaceutical composition for the improvement of dysuria.
MX9302870A (en) DERIVATIVES OF OCTAHIDRONAFTALENOXIMA FOR INHIBITION OF CHOLESTEROL BIOSYNTHESIS, ITS PREPARATION AND USE.
GB9218771D0 (en) Synergistic composition for dermatitis treatment
EP0643035A4 (en) Dermatologic preparation and novel benzoic acid derivative.
EP0402477A4 (en) Use of isocarbacyclins for preventing or treating organ diseases
AU628404B2 (en) Branched-chain alkyl esters of 2-(4-(2-piperidino-ethoxy)- benzoyl)-benzoic acid, processes for their preparation and their use as spasmolytic agents
IT1244696B (en) QUINOLONIC DERIVATIVE FOR ANTIBACTERIAL AND MUCOLITIC ACTIVITY
CA2012978A1 (en) Treatment of hepatic diseases using fk 506 and related compounds